AAC (NYSE:AAC) Upgraded by ValuEngine to “Hold”

ValuEngine upgraded shares of AAC (NYSE:AAC) from a sell rating to a hold rating in a research note released on Friday, July 19th, ValuEngine reports.

Several other research analysts also recently weighed in on AAC. Raymond James cut their price target on AAC from $7.00 to $5.00 and set an outperform rating for the company in a report on Thursday, April 18th. Zacks Investment Research upgraded AAC from a strong sell rating to a hold rating in a report on Tuesday, June 18th.

Shares of NYSE:AAC traded down $0.07 during trading on Friday, hitting $0.81. 65,214 shares of the stock were exchanged, compared to its average volume of 126,624. The company has a fifty day simple moving average of $0.97. The company has a market capitalization of $21.51 million, a P/E ratio of -0.76 and a beta of 2.43. The company has a debt-to-equity ratio of 3.37, a quick ratio of 0.17 and a current ratio of 0.17. AAC has a 12-month low of $0.62 and a 12-month high of $10.48.

AAC (NYSE:AAC) last issued its quarterly earnings data on Thursday, May 9th. The company reported ($0.79) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.13) by ($0.66). AAC had a negative return on equity of 39.45% and a negative net margin of 26.42%. The company had revenue of $55.37 million for the quarter, compared to analyst estimates of $75.16 million. As a group, research analysts predict that AAC will post -0.59 EPS for the current year.

In related news, insider Stephen Ebbett acquired 55,549 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The stock was acquired at an average cost of $0.80 per share, for a total transaction of $44,439.20. Following the completion of the acquisition, the insider now directly owns 65,549 shares of the company’s stock, valued at approximately $52,439.20. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Lucius E. Burch III bought 51,003 shares of AAC stock in a transaction that occurred on Monday, June 10th. The shares were acquired at an average price of $0.81 per share, with a total value of $41,312.43. Following the completion of the acquisition, the director now directly owns 1,270,482 shares of the company’s stock, valued at approximately $1,029,090.42. The disclosure for this purchase can be found here. Over the last ninety days, insiders have purchased 116,552 shares of company stock valued at $99,252. 31.22% of the stock is owned by corporate insiders.

A number of large investors have recently modified their holdings of AAC. Mondrian Investment Partners LTD boosted its holdings in AAC by 77.8% during the second quarter. Mondrian Investment Partners LTD now owns 1,122,132 shares of the company’s stock worth $965,000 after buying an additional 490,906 shares in the last quarter. Royce & Associates LP boosted its holdings in AAC by 20.8% during the first quarter. Royce & Associates LP now owns 1,862,185 shares of the company’s stock worth $3,426,000 after buying an additional 320,019 shares in the last quarter. GSA Capital Partners LLP boosted its holdings in AAC by 280.7% during the second quarter. GSA Capital Partners LLP now owns 373,458 shares of the company’s stock worth $321,000 after buying an additional 275,358 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in AAC by 47.0% during the fourth quarter. Bank of New York Mellon Corp now owns 175,579 shares of the company’s stock worth $246,000 after buying an additional 56,108 shares in the last quarter. Finally, Two Sigma Investments LP bought a new stake in AAC during the fourth quarter worth approximately $49,000. Hedge funds and other institutional investors own 46.36% of the company’s stock.

AAC Company Profile

AAC Holdings, Inc provides inpatient and outpatient substance use treatment services for individuals with drug addiction, alcohol addiction, and co-occurring mental/behavioral health issues in the United States. Its therapy services include motivational interviewing, cognitive behavioral therapy, rational emotive behavior therapy, dialectical behavioral therapy, solution-focused therapy, eye movement desensitization and reprocessing, and systematic family intervention.

Recommended Story: What is a Leveraged Buyout (LBO)?

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for AAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AAC and related companies with MarketBeat.com's FREE daily email newsletter.